News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
HALKUFF DAWN
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/07/2023 |
4
| HALKUFF DAWN (Director) has filed a Form 4 on Xeris Biopharma Holdings, Inc.|
Txns:
| Granted 42,500 shares
@ $0 |
|
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/05/2021 |
4
| HALKUFF DAWN (Director) has filed a Form 4 on Xeris Biopharma Holdings, Inc.|
Txns:
| Granted 19,650 options to buy
@ $12.5, valued at
$245.6k
Granted 20,000 options to buy
@ $10, valued at
$200k
Granted 11,228 options to buy
@ $4.68, valued at
$52.5k
Granted 11,228 options to buy
@ $3.9, valued at
$43.8k
|
|
| 10/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2020 |
4
| HALKUFF DAWN (Director) has filed a Form 4 on XERIS PHARMACEUTICALS INC|
Txns:
| Granted 11,228 options to buy
@ $4.68, valued at
$52.5k
|
|
| 03/01/2019 |
4
| HALKUFF DAWN (Director) has filed a Form 4 on XERIS PHARMACEUTICALS INC|
Txns:
| Granted 20,000 options to buy
@ $10, valued at
$200k
|
|
|
|